At the age of 63, George received a diagnosis that would fundamentally change his life: HPV-positive head and neck cancer. Now, post-treatment, he finds himself not only in recovery but in a position of purpose. His journey has been defined by determination, research, and self-advocacy—qualities deeply rooted in his professional background as a licensed social worker and Doctor of Behavioral Health.

From the beginning, he approached his diagnosis differently than many patients might. While he had full confidence in the medical professionals guiding his care, George also felt a strong need to understand every aspect of his condition. He quickly learned that HPV-positive head and neck cancer differs significantly from other forms of head and neck cancer, particularly in prognosis and patient outcomes. This raised an important question for him: if the disease is biologically different, why is the treatment approach often the same?

Driven by this question, George began researching extensively. What he discovered was both reassuring and eye-opening. Across the country, leading healthcare institutions were asking the same question and conducting clinical trials to explore whether less-intensive treatment could be just as effective. Some studies were evaluating shorter radiation courses—two or three weeks instead of the traditional seven—while still aiming for strong long-term survival outcomes.

The data George encountered showed promise but also presented a critical tradeoff. Some early attempts to reduce treatment intensity resulted in worse outcomes, reinforcing the importance of standard therapy. At the same time, ongoing clinical trials continue to explore whether more carefully designed approaches can safely reduce treatment while maintaining the high cure rates associated with current protocols. This uncertainty highlighted the complexity of treatment decision-making for patients like him.

After careful consideration, George chose to participate in a clinical trial designed to explore this very issue. The study randomized participants into two groups: one receiving three weeks of radiation and the other receiving the full seven weeks. The overarching goal of the trial, regardless of duration, was to preserve swallowing function—a quality-of-life outcome that is often severely impacted by radiation treatment in head and neck cancers.

I was randomized into the seven-week treatment group. While this initially felt like a return to the traditional path, there was a key difference: the use of advanced, targeted radiation techniques designed to minimize damage to critical structures involved in swallowing, explained George. This precision approach proved to be highly effective in my case, and I am grateful to report that my swallowing function has been largely preserved.

His treatment was not without its challenges. Like many patients undergoing radiation, I experienced fatigue, discomfort, and the emotional weight of uncertainty. However, my clinical knowledge, combined with a strong support system and a commitment to staying informed, allowed me to navigate these challenges with resilience. I understood not only what I was going through, but why it was happening, added George.

Today, as a cancer survivor, he has shifted his focus toward advocacy and education.

I am passionate about helping newly diagnosed patients understand that they have options, including participation in clinical trials, said George. While these trials represent the future of cancer treatment and may one day become the standard of care, it is essential for patients to weigh the potential benefits against the risks, especially when current treatments offer such high success rates.

George’s cancer journey has reinforced a core belief: patients must be active participants in their care. Asking questions, seeking second opinions, and exploring emerging research are not acts of defiance—they are acts of empowerment. As someone who has walked this path, he hopes to guide others in doing the same. Cancer changed my life, but it also gave me a renewed sense of purpose. I am not only a survivor; I am an advocate, an educator, and a voice for those just beginning their journey. If my experience can help even one person feel more informed, more confident, and less alone, then this journey has taken on a meaning far beyond my own survival.

Photo of Alliance Ambassador George Lowe - survivor of hpv-attributed oropharyngeal cancer

If my experience can help even one person feel more informed, more confident, and less alone, then this journey has taken on a meaning far beyond my own survival.

Head & Neck Cancer Alliance

STAY UPDATED!

SIGN UP For the newsletter

Keep up to date on the latest news from Head and Neck Cancer Alliance including upcoming webinars, program updates, general head and neck cancer news, and more.  We generally do not send more than 2-3 emails per month.